(Reuters) - Nearly a third of patients with advanced liver cancer who received a personalized vaccine developed by Geneos Therapeutics along with an immunotherapy drug in a small, early trial saw their tumors shrink, U.S. researchers reported on Sunday.
Adding a personalized anti-tumor vaccine to standard immunotherapy is safe and about twice as likely to shrink cancer as standard immunotherapy alone for patien
Geneos cancer vaccine shrinks liver tumors in small trial biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
Press Release Stockholm, Sweden, November 13, 2023 The shareholders of Mendus AB , reg. no 556629-1786, are hereby invited to the Extraordinary General Meeting on Wednesday, 13.